Market Mixed Amid Plan To Spend $300 Million On Ebola Vaccines
December 11, 2014 at 14:14 PM EST
Ebola-related pharma stocks were mixed Thursday amid plans announced to buy millions of doses of vaccines for the disease once the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.